Clinical Trials
2 trialsNCT04826341 2026-05-29
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
National Institutes of Health Clinical Center (CC)
Phase 1/2 Active not recruiting
NCT02157792 2020-04-01
M6620 First in Human Study
EMD Serono
Phase 1 Completed